Linked Data API

Show Search Form

Search Results

1689268
star this property registered interest false more like this
star this property date less than 2024-02-16more like thismore than 2024-02-16
star this property answering body
Foreign, Commonwealth and Development Office more like this
star this property answering dept id 208 more like this
star this property answering dept short name Foreign, Commonwealth and Development Office more like this
star this property answering dept sort name Foreign, Commonwealth and Development Office more like this
star this property hansard heading Karim Ennarah more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Minister of State, Foreign, Commonwealth and Development Office, when his Department last raised the case of Karim Ennarah with the Egyptian Government. more like this
star this property tabling member constituency Bethnal Green and Bow remove filter
star this property tabling member printed
Rushanara Ali more like this
star this property uin 14086 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2024-02-26more like thismore than 2024-02-26
star this property answer text <p>The Minister for North Africa, Lord (Tariq) Ahmad of Wimbledon, last raised Karim Ennarah's case with the Egyptian Ambassador on 20 February 2024 and also raised this case with Foreign Minister Shoukry during his visit to Cairo last year. Our Embassy in Cairo continues to raise the challenges faced by human rights defenders with the Egyptian authorities, and UK representatives have also done so via Item IV Statements at the Human Rights Council. Human rights defenders make a vital contribution to the health of all societies and should be able to conduct their work and lives unimpeded in Egypt, fully benefiting from their rights under the Egyptian Constitution.</p> more like this
unstar this property answering member constituency Macclesfield more like this
star this property answering member printed David Rutley more like this
star this property question first answered
less than 2024-02-26T17:40:35.38Zmore like thismore than 2024-02-26T17:40:35.38Z
star this property answering member
4033
star this property label Biography information for David Rutley more like this
star this property tabling member
4138
star this property label Biography information for Rushanara Ali more like this
1666828
star this property registered interest false more like this
star this property date less than 2023-10-24more like thismore than 2023-10-24
star this property answering body
Department for Levelling Up, Housing and Communities more like this
star this property answering dept id 211 more like this
star this property answering dept short name Levelling Up, Housing and Communities more like this
star this property answering dept sort name Levelling Up, Housing and Communities more like this
star this property hansard heading Housing Associations: Maladministration more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Levelling Up, Housing and Communities, what proportion of maladministration cases have been due to unreasonable delays from housing associations each of the last 5 years. more like this
star this property tabling member constituency Bethnal Green and Bow remove filter
star this property tabling member printed
Rushanara Ali more like this
star this property uin 204021 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2023-10-26more like thismore than 2023-10-26
star this property answer text <p>It has not proved possible to respond to the hon. Member in the time available before Prorogation.</p> more like this
unstar this property answering member constituency Redcar more like this
star this property answering member printed Jacob Young more like this
star this property question first answered
less than 2023-10-26T10:17:31.07Zmore like thismore than 2023-10-26T10:17:31.07Z
star this property answering member
4825
star this property label Biography information for Jacob Young more like this
star this property tabling member
4138
star this property label Biography information for Rushanara Ali more like this
1666557
star this property registered interest false more like this
star this property date less than 2023-10-23more like thismore than 2023-10-23
star this property answering body
Foreign, Commonwealth and Development Office more like this
star this property answering dept id 208 more like this
star this property answering dept short name Foreign, Commonwealth and Development Office more like this
star this property answering dept sort name Foreign, Commonwealth and Development Office more like this
star this property hansard heading Myanmar: Human Rights more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what assessment he has made of the implications for his policies of the report of the United Nations High Commissioner for Human Rights A/HRC/54/59: Situation of human rights in Myanmar, published on 19 September 2023. more like this
star this property tabling member constituency Bethnal Green and Bow remove filter
star this property tabling member printed
Rushanara Ali more like this
star this property uin 203845 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2023-10-26more like thismore than 2023-10-26
star this property answer text <p>The UK shares the findings of the report of the UN High Commissioner for Human Rights on the increasingly dire human rights situation in Myanmar. We remain committed to targeting the regime's access to finance and arms, including through sanctions on the military leadership to inhibit access to revenue and equipment. Accountability is key in stopping the atrocities committed against the Myanmar people. To support the preservation of evidence for future prosecution, we have provided over £600,000 to the Independent Investigative Mechanism for Myanmar and established the Myanmar Witness project. Continued humanitarian access and assistance remains a UK priority in Myanmar.</p> more like this
unstar this property answering member constituency Berwick-upon-Tweed more like this
star this property answering member printed Anne-Marie Trevelyan more like this
star this property question first answered
less than 2023-10-26T09:08:41.517Zmore like thismore than 2023-10-26T09:08:41.517Z
star this property answering member
4531
star this property label Biography information for Anne-Marie Trevelyan more like this
star this property tabling member
4138
star this property label Biography information for Rushanara Ali more like this
1666558
star this property registered interest false more like this
star this property date less than 2023-10-23more like thismore than 2023-10-23
star this property answering body
Foreign, Commonwealth and Development Office more like this
star this property answering dept id 208 more like this
star this property answering dept short name Foreign, Commonwealth and Development Office more like this
star this property answering dept sort name Foreign, Commonwealth and Development Office more like this
star this property hansard heading Myanmar: Military Aid more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what steps he is taking to encourage his international counterparts to stop the supply of (a) arms, (b) military equipment, (c) fuel and (d) funds to Myanmar. more like this
star this property tabling member constituency Bethnal Green and Bow remove filter
star this property tabling member printed
Rushanara Ali more like this
star this property uin 203846 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2023-10-26more like thismore than 2023-10-26
star this property answer text <p>Since the coup in February 2021, the UK has announced fifteen rounds of targeted sanctions on the military leadership and those who seek to profit from supplying the regime in Myanmar. The UK continues to work closely with international partners, including the US, EU and Canada, to take robust action to reduce the military's access to arms, military equipment, fuel and funds and to pressure those who sell arms to the military. We have used, and will continue to use, our role at the G7 and the UN to this end.</p> more like this
unstar this property answering member constituency Berwick-upon-Tweed more like this
star this property answering member printed Anne-Marie Trevelyan more like this
star this property question first answered
less than 2023-10-26T08:55:50.687Zmore like thismore than 2023-10-26T08:55:50.687Z
star this property answering member
4531
star this property label Biography information for Anne-Marie Trevelyan more like this
star this property tabling member
4138
star this property label Biography information for Rushanara Ali more like this
1666559
star this property registered interest false more like this
star this property date less than 2023-10-23more like thismore than 2023-10-23
star this property answering body
Foreign, Commonwealth and Development Office more like this
star this property answering dept id 208 more like this
star this property answering dept short name Foreign, Commonwealth and Development Office more like this
star this property answering dept sort name Foreign, Commonwealth and Development Office more like this
star this property hansard heading Vaccination: International Cooperation more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what steps his Department is taking to support global immunisation and vaccination efforts; and if he will make a statement. more like this
star this property tabling member constituency Bethnal Green and Bow remove filter
star this property tabling member printed
Rushanara Ali more like this
star this property uin 203847 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2023-10-26more like thismore than 2023-10-26
star this property answer text <p>The COVID-19 pandemic dramatically impacted global health and immunisation. The UK Government is committed to supporting efforts to get routine immunisation back on track and has invested £1.65 billion to Gavi, the Vaccine Alliance from 2021-2025 to support their mission to immunise 300 million children and save up to 8 million lives from vaccine preventable diseases over this period. The UK has supported Gavi since its inception in 2000, during which time Gavi has vaccinated more than 1 billion children in 78 lower-income countries, saving over 17 million lives. Alongside our Gavi investment, we are working with countries to build stronger primary health care systems as a core part of restoring immunisation services.</p> more like this
unstar this property answering member constituency Sutton Coldfield more like this
star this property answering member printed Mr Andrew Mitchell more like this
star this property question first answered
less than 2023-10-26T08:02:13.463Zmore like thismore than 2023-10-26T08:02:13.463Z
star this property answering member
1211
star this property label Biography information for Mr Andrew Mitchell more like this
star this property tabling member
4138
star this property label Biography information for Rushanara Ali more like this
1649373
star this property registered interest false more like this
star this property date less than 2023-06-30more like thismore than 2023-06-30
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Clinical Trials more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps the Medicines and Healthcare products Regulatory Agency is taking to reduce the time it takes to assess human challenge clinical trials. more like this
star this property tabling member constituency Bethnal Green and Bow remove filter
star this property tabling member printed
Rushanara Ali more like this
star this property uin 191919 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2023-07-05more like thismore than 2023-07-05
star this property answer text <p>The Medicines Healthcare products Regulatory Agency (MHRA) is aware that customers who have submitted initial applications and amendments to our Clinical Investigations and Trials team have experienced extended timeframes in some cases and understands how this unpredictability is impacting companies. The MHRA has taken several significant steps to address the extended timeframes for clinical trial approvals. This includes, but is not limited to, prioritising recruitment and training of specialist staff, working with external stakeholders to streamline and improve its processes, and enhancing customer service support and communications. The MHRA regularly reviews and prioritises applications based on public health impact, patient safety and patient need. Unless a human challenge trial application is considered to meet those criteria it is not prioritised over other clinical trial applications.</p> more like this
unstar this property answering member constituency Colchester more like this
star this property answering member printed Will Quince more like this
star this property question first answered
less than 2023-07-05T15:19:28.81Zmore like thismore than 2023-07-05T15:19:28.81Z
star this property answering member
4423
star this property label Biography information for Will Quince more like this
star this property tabling member
4138
star this property label Biography information for Rushanara Ali more like this
1649374
star this property registered interest false more like this
star this property date less than 2023-06-30more like thismore than 2023-06-30
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Clinical Trials more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, whether the Medicines and Healthcare products Regulatory Agency expedites human challenge trial applications where a case has gone beyond its 60-day review deadline. more like this
star this property tabling member constituency Bethnal Green and Bow remove filter
star this property tabling member printed
Rushanara Ali more like this
star this property uin 191920 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2023-07-05more like thismore than 2023-07-05
star this property answer text <p>The Medicines and Healthcare product Regulatory Agency (MHRA) is dealing with queued applications sequentially. However, the MHRA is reallocating work and routinely evaluates applications for their complexity and prioritises applications based on public health impact, patient safety and patient need. This approach applies to all queued clinical trials including human challenge trial applications that have exceeded the 60-day review deadline.</p> more like this
unstar this property answering member constituency Colchester more like this
star this property answering member printed Will Quince more like this
star this property question first answered
less than 2023-07-05T15:20:54.26Zmore like thismore than 2023-07-05T15:20:54.26Z
star this property answering member
4423
star this property label Biography information for Will Quince more like this
star this property tabling member
4138
star this property label Biography information for Rushanara Ali more like this
1649375
star this property registered interest false more like this
star this property date less than 2023-06-30more like thismore than 2023-06-30
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Clinical Trials more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, how many clinical trial protocols have been awaiting approval by the Medicines and Healthcare products Regulatory Agency for more than (a) 30, (b) 60 and (c) 120 days. more like this
star this property tabling member constituency Bethnal Green and Bow remove filter
star this property tabling member printed
Rushanara Ali more like this
star this property uin 191921 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2023-07-05more like thismore than 2023-07-05
star this property answer text <p>As of 5 July 2023, the number of clinical trial protocols, initial clinical trial authorisation applications, that have been awaiting approval by the Medicines and Healthcare products Regulatory Agency (MHRA) for more than 30 days (31 to 60 days inclusive) is 68, for more than 60 days (61 to 120 days inclusive) is 110 and for more than 120 days (121 days+) is 81. The MHRA publishes this data about its performance on its website every month.</p> more like this
unstar this property answering member constituency Colchester more like this
star this property answering member printed Will Quince more like this
star this property question first answered
less than 2023-07-05T14:35:11.747Zmore like thismore than 2023-07-05T14:35:11.747Z
star this property answering member
4423
star this property label Biography information for Will Quince more like this
star this property tabling member
4138
star this property label Biography information for Rushanara Ali more like this
1645689
star this property registered interest false more like this
star this property date less than 2023-06-19more like thismore than 2023-06-19
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Clinical Trials more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure the Medicines and Healthcare products Regulatory Agency meets its statutory obligation to assess clinical trials within 60 days of notification. more like this
star this property tabling member constituency Bethnal Green and Bow remove filter
star this property tabling member printed
Rushanara Ali more like this
star this property uin 190132 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2023-06-26more like thismore than 2023-06-26
star this property answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) is committed to making regulatory decisions in accordance with statutory timeframes. The MHRA has recently undertaken a significant recruitment exercise to bring on board new specialist staff to increase clinical trial assessor capacity within the Agency. The MHRA are supplementing this new assessor capacity with additional fixed-term resource of appropriately experienced and qualified specialists to support the training and supervision of new staff.</p><p>The MHRA continue to develop plans to increase staff capability and expertise, and to review internal processes for efficiencies. To that end, significant progress has been made to draft proposals for how a risk-proportionate approach to clinical trial assessments could be implemented.</p><p>Following public consultation, the MHRA plans to reform national legislation to deliver a world-class sovereign regulatory environment for clinical trials that will support the development of innovative medicines and ensure that the UK retains and grows its reputation as a world leading base for life sciences.</p>
unstar this property answering member constituency Colchester more like this
star this property answering member printed Will Quince more like this
star this property grouped question UIN 190133 more like this
star this property question first answered
less than 2023-06-26T15:01:18.43Zmore like thismore than 2023-06-26T15:01:18.43Z
star this property answering member
4423
star this property label Biography information for Will Quince more like this
star this property tabling member
4138
star this property label Biography information for Rushanara Ali more like this
1645690
star this property registered interest false more like this
star this property date less than 2023-06-19more like thismore than 2023-06-19
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Clinical Trials more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the time taken to conduct clinical trial approvals by the Medicines and Healthcare products Regulatory Agency on the UK's life sciences sector. more like this
star this property tabling member constituency Bethnal Green and Bow remove filter
star this property tabling member printed
Rushanara Ali more like this
star this property uin 190133 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2023-06-26more like thismore than 2023-06-26
star this property answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) is committed to making regulatory decisions in accordance with statutory timeframes. The MHRA has recently undertaken a significant recruitment exercise to bring on board new specialist staff to increase clinical trial assessor capacity within the Agency. The MHRA are supplementing this new assessor capacity with additional fixed-term resource of appropriately experienced and qualified specialists to support the training and supervision of new staff.</p><p>The MHRA continue to develop plans to increase staff capability and expertise, and to review internal processes for efficiencies. To that end, significant progress has been made to draft proposals for how a risk-proportionate approach to clinical trial assessments could be implemented.</p><p>Following public consultation, the MHRA plans to reform national legislation to deliver a world-class sovereign regulatory environment for clinical trials that will support the development of innovative medicines and ensure that the UK retains and grows its reputation as a world leading base for life sciences.</p>
unstar this property answering member constituency Colchester more like this
star this property answering member printed Will Quince more like this
star this property grouped question UIN 190132 more like this
star this property question first answered
less than 2023-06-26T15:01:18.507Zmore like thismore than 2023-06-26T15:01:18.507Z
star this property answering member
4423
star this property label Biography information for Will Quince more like this
star this property tabling member
4138
star this property label Biography information for Rushanara Ali more like this